Kretzschmar, M
Thymosin Alpha-1 is an immune-modulating compound that is formally approved as a pharmaceutical product in more than 30 countries including Italy, China, and several Southeast Asian nations for the treatment of hepatitis B, hepatitis C, and as an immune adjuvant in oncology
0.040.10 g Se/g diet (Yang et al., 1989
[181] The Blue Mountains Eye Study reported a higher prevalence of posterior subcapsular cataracts among users of high-dose thiamine and pyridoxine (vitamin B6) supplements
Liver histological features include centrilobular necroinflammation, central perivenulitis, interface hepatitis, lymphoid aggregates, and massive hepatic necrosis [167,168,169,170,171,172,173] (Supplementary Table 3)